Capitol Hill News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Senate passage sends trade promotion authority bill to President Obama for his signature; House “21st Century Cures” legislation gains 230 co-sponsors in the House; Senate Finance panel marks up disposable medical technologies bill.
You may also be interested in...
Senate Bill Tackles 'Least Burdensome,' Centralized IRBs, CLIA Waivers
The targeted FDA Device Accountability Act mirrors select device sections of the House 21st Century Cures legislation seeking to strengthen the use of "least-burdensome" provisions, allow use of centralized IRBs for device trials and refining standards for diagnostic CLIA waivers.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.